Change is Inevitable: Updates in the Management of Breast Cancer Therapy

Friday, February 3, 2:30-3:30 PM

Accredited for Pharmacists


Breast cancer is the most common malignancy in patients assigned female (at birth) in the United States. Breast cancer is also the second-highest cause of cancer-related death. In fact, one in eight individuals assigned female (at birth) will develop breast cancer in their lifetime. Subsequently, education on screening, prevention, and treatment strategies for breast cancer is needed. This course will highlight newly-approved therapies for the treatment of breast cancer to enable pharmacist provision of up-to-date, guideline-based care for patients.

Learning Objectives - Pharmacists
Upon successful completion of this application-based CPE activity, participants should be able to:

  1. Identify relevant oncogenic targets for patients with breast cancer.
  2. Interpret results of IHC or FISH testing to guide treatment for patients with breast cancer.
  3. Describe the clinical trials and outcomes of key studies evaluating new therapies for the treatment of patients with breast cancer.
  4. Recommend appropriate, evidence-based, patient-specific treatment and monitoring for the management of breast cancer.
  5. Compare previous standard-of-care regimens to newly approved treatment options for patients with various forms of breast cancer.

0.1 CEU/1 hr
UAN: 0107-0000-23-036-L01-P

Anna Shook, PharmD, BCPS, BCOP
Assistant Professor, Drake University College of Pharmacy

Speaker Bios